文献速递银屑病与炎症性皮肤病

抑郁症是银屑病主要共病,由代谢性炎症引起

Depression, a major comorbidity of psoriatic disease, is caused by metabolic inflammation.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2023-06-02

银屑病是一种慢性系统性免疫介导炎症性疾病,可累及皮肤、血管和骨关节,常伴高血压、血脂异常、糖尿病和抑郁症,高达五分之一的银屑病患者合并抑郁症。本文综述认为银屑病相关抑郁症与IL-23、IL-17家族细胞因子、TNF、IL-6和IL-8介导的神经炎症相关,肥胖和吸烟是重要危险因素,TNF、IL-17和IL-23抑制剂等靶向治疗可改善抑郁症状。

要点

  • 高达五分之一的银屑病患者合并抑郁症,抑郁症是银屑病主要共病。
  • 银屑病相关抑郁症与IL-23、IL-17家族细胞因子、TNF、IL-6和IL-8介导的神经炎症相关。
  • 肥胖和吸烟是银屑病最重要的危险因素;TNF、IL-17和IL-23抑制剂可改善抑郁症状。

核心结论

  • 银屑病相关抑郁症与特定炎症模式相关,而非仅由慢性病的心理应激所致。
  • IL-23、IL-17家族细胞因子、TNF、IL-6和IL-8引起神经炎症,进而导致抑郁或抑郁行为和/或焦虑。
  • 除心理治疗和抗抑郁药物外,包括TNF、IL-17和IL-23抑制剂在内的银屑病靶向治疗可改善抑郁/抑郁症状。

研究设计与样本

  • 本文为综述,总结当前关于银屑病共病抑郁症的知识。

主要发现

  • 高达五分之一的银屑病患者合并抑郁症。
  • 银屑病在皮肤、血管和骨/关节三个主要领域均显示独特的免疫细胞(如树突状细胞、Th17细胞、中性粒细胞)、介质(如IL-17A/F、IL-23、TNF)和组织相关因子模式,不同于其他炎症性皮肤病。
  • 银屑病的炎症模式与导致抑郁症的神经炎症高度相似。
  • 银屑病中已识别多个危险因素,其中最重要的是肥胖和吸烟。
  • 肥胖因其炎症特征而成为抑郁和焦虑的主要危险因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Psoriatic disease is a chronic, systemic immune-mediated inflammatory disorder comprising three major domains, skin, vascular and bone/joint inflammation. It is known for a long time that psoriatic disease is associated with a number of conditions such as hypertension, dyslipidemia, diabetes (metabolic syndrome) and depression. Up to one out of five people with psoriasis show concomitant depression. In the past, this was attributed to psychological stress of suffering from a chronic condition that is often visible and itchy, leading to stigmatization and adding to a significant burden of disease. Recent data provide evidence that depression associated with psoriatic disease is linked to the specific inflammatory pattern with IL-23, IL-17 family cytokines, TNF, IL-6 and IL-8 causing neuroinflammation and subsequently depression or depressive behaviour and/or anxiety. Psoriatic disease shows a distinct pattern of immune cells (e.g. dendritic cells, Th17 cells, neutrophils), mediators (e.g. IL-17A/F, IL-23, TNF) and tissue-related factors in all major domains that is different from other inflammatory dermatoses. There is a striking similarity between the inflammatory pattern in psoriatic disease and neuroinflammation that leads to depression. A number of risk factors have been identified in psoriatic disease, the most important of which are obesity and tobacco smoking. Obesity is known as a major risk factor for depression and anxiety due to its inflammatory signature. Apart from psychotherapy and anti-depressive medication, targeted treatments for psoriasis, including TNF, IL-17 and IL-23 inhibitors, can improve depression/depressive symptoms. The review summarizes the current knowledge about depression as a comorbidity in psoriatic disease.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Mrowietz U, Sümbül M, Gerdes S, et al. Depression, a major comorbidity of psoriatic disease, is caused by metabolic inflammation. J Eur Acad Dermatol Venereol. 2023. PMID: 37184282. doi:10.1111/jdv.19192

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。